Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004438 · ClinicalTrials.gov registry record · NA
Leuprolide in Treating Adults With Hypogonadotropism
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00004438 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 45 participants.
The verdict
NCT00004438, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
RATIONALE: Hypogonadotropism is an abnormal condition caused by decreased production of gonadotropins, a group of hormones that stimulate the parts of the reproductive system that produce and release eggs from the ovaries or sperm from the testicles. Leuprolide may stimulate the production of gonadotropins and be effective in increasing testosterone in men and inducing ovulation in women. PURPOSE: Clinical trial to study the effectiveness of leuprolide in treating adults who have hypogonadotropism.
Interventions
- DRUG leuprolide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 1997-09 |
| Est. Completion | 2002-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004438
The ClinicalTrials.gov registry entry for NCT00004438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which leuprolide is the first listed.
NCT00004438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004438 about?
NCT00004438 is a clinical study titled "Leuprolide in Treating Adults With Hypogonadotropism". RATIONALE: Hypogonadotropism is an abnormal condition caused by decreased production of gonadotropins, a group of hormones that stimulate the parts of the reproductive system that produce and release eggs from the ovaries or sperm from the testicles. Leuprolide may stimulate the production of gonado...
What is the current status of trial NCT00004438?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 1997-09. Estimated completion is 2002-09.
What interventions are being tested in trial NCT00004438?
The interventions under investigation include: leuprolide (DRUG).
Who is sponsoring clinical trial NCT00004438?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.